Chrysalis Investments just dropped their interim results, and there’s plenty to unpack. While the market’s been wobbling like a unicycle on cobblestones, this growth-focused investment trust has quietly delivered an 8% jump in NAV per share since last September. Let’s slice through the jargon and see what’s really moving the needle.
The Headline Numbers: Growth Amidst Contraction
First, the raw stats – because numbers don’t lie (though they sometimes whisper half-truths):
- NAV per share: 152.62p (up from 141.26p in Sept 2024)
- Share price: 91.90p (a slight 1.5% dip, but keep reading…)
- Total net assets: £827m (down 1.5%)
Spot the disconnect? While NAV per share climbed, total net assets shrank. That’s no accounting glitch – it’s the deliberate result of Chrysalis’s aggressive share buyback programme, which we’ll dig into shortly.
Strategic Shifts: Selling, Buying, and Doubling Down
Chrysalis hasn’t been sitting on its hands. The period saw surgical portfolio manoeuvres:
Exits: Cashing Chips
- £80m realisations during the period, primarily from selling AI firm Featurespace (£79m)
- Another £49m banked post-period from InfoSum’s sale
Reinvestments: Betting Heavier on Winners
- wefox (insurtech): £17m follow-on
- Klarna (BNPL giant): £8m top-up
- InfoSum (data collaboration): £2m (pre-exit, showing nimble timing)
This isn’t random tinkering. Chrysalis is deliberately concentrating firepower on its “later-stage crown jewels” – notably Klarna and Starling Bank. As Chair Andrew Haining put it: the remaining portfolio holds “the most exciting valuation upside.”
The Buyback Blitz: Shrinking the Discount
Here’s where things get spicy. Chrysalis is hammering its own discount like a blacksmith at the forge:
- £51.7m returned via buybacks by March 2025
- £68.9m total to date – that’s 11.9% of shares vacuumed up
- Targeting up to £100m in total repurchases
Why the self-cannibalisation? Simple maths: buying shares below NAV accretes value for remaining holders. And it’s working. Post-period, the share price leapt 14%, narrowing the discount from a cavernous 40% to 31%. Haining’s clearly not done: the board is “evaluating options to further reduce the discount.”
Starling & Klarna: The Portfolio Heavyweights
With disposals complete, Chrysalis’s fate now hinges on two giants:
Starling Bank (33% of NAV)
The digital bank isn’t just a holding – it’s the thesis. Investment Advisers Watts and Williamson highlighted:
- Potential to “reaccelerate UK growth“
- Monetising its tech platform “Engine” globally
- Already profitable on an adjusted basis (like all top 5 holdings)
Klarna (Undisclosed % but top 5 holding)
The “buy now, pay later” poster child could deliver fireworks:
- Recent “cost control” praised by advisers
- Post-period stock market rebound “potentially supporting a Klarna IPO“
With these two comprising over a third of NAV between them, Chrysalis has effectively bet the farm on European fintech disruption.
Looking Ahead: Capital, Consultation, and Catalysts
Three things to watch:
- Capital Allocation Policy (CAP) Review: The board will propose changes at the 2026 AGM, consulting shareholders first. Haining’s urging investors to “take part.” Translation: your views on further buybacks vs. dividends matter.
- Unexpected Liquidity: Faster-than-expected exits (Graphcore, Featurespace, InfoSum) mean Chrysalis is flush with cash – creating optionality.
- Market Tailwinds: A recovering IPO market could finally unlock Klarna’s value. Starling’s “Engine” monetisation? That’s the sleeper catalyst.
The Bottom Line
Chrysalis is evolving – shedding minnows to feed the sharks. The 8% NAV jump proves the strategy has legs, while relentless buybacks signal management’s confidence (and impatience with the discount).
Risks? Absolutely. This is now a concentrated bet on late-stage private tech. But with Starling’s growth levers and Klarna’s IPO potential, there’s genuine rocket fuel here. As Watts and Williamson noted: the portfolio’s ability to deliver value has “substantially improved.” For discount hunters? That narrowing 31% gap looks like an invitation.